SCHEMBL5730835

SCHEMBL5730835

COc1cc(CSN2C=NCC2)cc(OC)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.36
CASP4 P49662 1/20 0.36
CASP5 P51878 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2E1 P05181 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C8 P10632 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2B6 P20813 1/20 0.35
BRS3 P32247 1/20 0.35
CYP2C19 P33261 1/20 0.35
TSHR P16473 2/20 0.34
GFER P55789 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HRH3 Q9Y5N1 1/20 0.33
TP53 P04637 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
DRD4 P21917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5730151 0.86 HRH3 (0.48) CASP1CASP4CASP5CYP1A2ALDH1A1
SCHEMBL5731587 0.85 HRH3 (0.43) CYP3A4TSHRALDH1A1HRH3TP53
SCHEMBL5731404 0.73 POLB (0.44) TSHRGFERALDH1A1HRH3MEN1
SCHEMBL5730937 0.69
SCHEMBL5732705 0.69 KMT2A (0.48) CYP2C9CYP2C19TSHRGFERALDH1A1
SCHEMBL5732829 0.68 HRH3 (0.49) CYP1A2CYP2C19ALDH1A1HRH3TP53
SCHEMBL8844090 0.67
SCHEMBL5731478 0.67 KDM4E (0.44) CASP1CASP4CASP5ALDH1A1HRH3
SCHEMBL5731045 0.65 L3MBTL1 (0.39) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL18896261 0.65 ALDH1A1 (0.52) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651613-A1 4,5-DIHYDRO-IMIDAZOLE AS P2X7 ION CHANNEL BLOCKERS Aventis Pharmaceuticals, Inc. (US) 2006-05-03 EP disclosed
WO-2005014555-A1 4,5-DIHYDRO-IMIDAZOLE AS P2X7 ION CHANNEL BLOCKERS AVENTIS PHARMACEUTICALS INC. (US) 2005-02-17 WO disclosed